BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38939604)

  • 1. Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the Possibilities.
    Ng TMH
    JACC Adv; 2023 May; 2(3):100354. PubMed ID: 38939604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telephone-Based Guideline-Directed Medical Therapy Optimization in Navajo Nation: The Hózhó Randomized Clinical Trial.
    Eberly LA; Tennison A; Mays D; Hsu CY; Yang CT; Benally E; Beyuka H; Feliciano B; Norman CJ; Brueckner MY; Bowannie C; Schwartz DR; Lindsey E; Friedman S; Ketner E; Detsoi-Smiley P; Shyr Y; Shin S; Merino M
    JAMA Intern Med; 2024 Jun; 184(6):681-690. PubMed ID: 38583185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DASH-HF Study: A Pragmatic Quality Improvement Randomized Implementation Trial for Patients With Heart Failure With Reduced Ejection Fraction.
    Verma A; Fonarow GC; Hsu JJ; Jackevicius CA; Vaghaiwalla Mody F; Nguyen A; Amidi O; Goldberg S; Vetrivel R; Upparapalli D; Theodoropoulos K; Gregorio S; Chang DS; Bostrom K; Althouse AD; Ziaeian B
    Circ Heart Fail; 2023 Sep; 16(9):e010278. PubMed ID: 37494051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of Guideline-Directed Medical Therapy for Coronary Heart Disease and Ischemic Heart Failure Outcomes.
    Crosier R; Austin PC; Ko DT; Lawler PR; Stukel TA; Farkouh ME; Wang X; Spertus JA; Ross HJ; Lee DS
    Am J Med; 2021 May; 134(5):672-681.e4. PubMed ID: 33181105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computerized Advisory Decision Support for Cardiovascular Diseases in Primary Care: A Cluster Randomized Trial.
    McKie PM; Kor DJ; Cook DA; Kessler ME; Carter RE; Wilson PM; Pencille LJ; Hickey BC; Chaudhry R
    Am J Med; 2020 Jun; 133(6):750-756.e2. PubMed ID: 31862329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital Initiation and Up-titration of Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction.
    Cox ZL; Nandkeolyar S; Johnson AJ; Lindenfeld J; Rali AS
    Card Fail Rev; 2022 Jan; 8():e21. PubMed ID: 35815257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financial Toxicity of Medical Management of Heart Failure: JACC Review Topic of the Week.
    Sukumar S; Wasfy JH; Januzzi JL; Peppercorn J; Chino F; Warraich HJ
    J Am Coll Cardiol; 2023 May; 81(20):2043-2055. PubMed ID: 37197848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A guideline-based computerised decision support system (CDSS) to influence general practitioners management of chronic heart failure.
    Toth-Pal E; Wårdh I; Strender LE; Nilsson G
    Inform Prim Care; 2008; 16(1):29-39. PubMed ID: 18534075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Approaches to Patients with Heart Failure.
    Mitter SS; Yancy CW
    Cardiol Clin; 2017 May; 35(2):261-271. PubMed ID: 28411900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure.
    Shahid I; Khan MS; Fonarow GC; Butler J; Greene SJ
    Prog Cardiovasc Dis; 2024; 82():61-69. PubMed ID: 38244825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.
    Krittanawong C; Rodriguez M; Lui M; Misra A; Tang WHW; Bozkurt B; Yancy CW
    Am J Med; 2023 May; 136(5):422-431. PubMed ID: 36740210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure.
    Ahn MS; Yoo BS; Yoon J; Lee SH; Kim JY; Ahn SG; Youn YJ; Lee JW; Son JW; Kim HS; Kang DR; Lee SE; Cho HJ; Lee HY; Jeon ES; Kang SM; Choi DJ; Cho MC
    J Korean Med Sci; 2019 May; 34(17):e133. PubMed ID: 31050223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
    Çöllüoğlu İT; Çelik A; Ata N; Ural D; Şahin A; Ulgu MM; Kanık EA; Birinci Ş; Yılmaz MB
    Int J Cardiol; 2024 Jul; 407():132109. PubMed ID: 38703896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial.
    Brahmbhatt DH; Ross HJ; O'Sullivan M; Artanian V; Mueller B; Runeckles K; Steve Fan CP; Rac VE; Seto E;
    JACC Heart Fail; 2024 Apr; 12(4):678-690. PubMed ID: 38569821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing Guideline-Directed Medical Therapy for Heart Failure - Challenges and Strategies.
    Onoue K
    Circ J; 2023 Dec; 88(1):31-32. PubMed ID: 38030299
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimizing Background Therapy for Heart Failure in Clinical Trials: Towards a More Objective Approach.
    Desai AS; Deswal A; McMurray JJV; Pinney SP; Vaduganathan M
    JACC Heart Fail; 2023 Jul; 11(7):806-809. PubMed ID: 37407155
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of Multidisciplinary Heart Failure Clinic on Guideline-Directed Medical Therapy and Clinical Outcomes.
    Tan SS; Hisham SA; Bin Abdul Malek AM; Lik CP; Lau GSK; Bin Abdul Ghapar AK
    Can J Hosp Pharm; 2024; 77(1):e3364. PubMed ID: 38204512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenge of Optimizing Medical Therapy in Heart Failure: Unlocking the Potential of Digital Health and Patient Engagement.
    Azizi Z; Golbus JR; Spaulding EM; Hwang PH; Ciminelli ALA; Lacar K; Hernandez MF; Gilotra NA; Din N; Brant LCC; Au R; Beaton A; Nallamothu BK; Longenecker CT; Martin SS; Dorsch MP; Sandhu AT
    J Am Heart Assoc; 2024 Jan; 13(2):e030952. PubMed ID: 38226520
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences in provider approach to initiating and titrating guideline directed medical therapy in heart failure with reduced ejection fraction.
    Cordwin DJ; Guidi J; Alhashimi L; Hummel SL; Koelling TM; Dorsch MP
    BMC Cardiovasc Disord; 2024 May; 24(1):247. PubMed ID: 38730379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging clinical decision support tools to improve guideline-directed medical therapy in patients with atherosclerotic cardiovascular disease at hospital discharge.
    Vani A; Kan K; Iturrate E; Levy-Lambert D; Smilowitz NR; Saxena A; Radford MJ; Gianos E
    Cardiol J; 2022; 29(5):791-797. PubMed ID: 32986236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.